The TNF family ligand Ectodysplasin A (EDA) regulates the induction, morphogenesis and/or maintenance of skin-derived structures such as teeth, hair, sweat glands and several other glands.
potentiate its ability to stimulate EDAR signalling (Schneider et al., 2001; Swee et al., 2009) (Fig. 1A,B) . Finally, the proteoglycan-binding domain of EDA, which is mostly coded by the very short exon 3, may restrict EDA diffusion in tissues once it is released in a soluble form (Swee et al., 2009) (Fig. 1B) . Mutations in the proteoglycan-binding region have not been reported in XLHED patients, either because this interaction is not essential for the function of EDA, or because disruption of the interaction can be achieved neither with a single point mutation nor with exon 3 deletion, which would induce a frame shift.
EDAR
EDAR is a typical TNF receptor family member with a signal peptide, three cystein-rich domains (CRDs), a transmembrane domain and an intracellular region comprising a so-called "death domain" (Headon and Overbeek, 1999) (Fig. 1A) . Most mutations in patients with autosomal HED are located within CRD2, which is involved in ligand binding, or within the death domain, which is involved in signal transmission (Fig. 1A) . A function activating polymorphism (Val370Ala) found in the death domain of EDAR in East Asian and Native American populations is associated with a thicker hair phenotype (Mou et al., 2008; Sabeti et al., 2007) . In the death receptors Fas and TRAILR2, the death domain recruits Fas-associated protein with a death domain (FADD) , that itself recruits and activates cystein proteases of the caspase family to execute apoptotic cell death. EDAR does not interact with FADD, but instead recruits EDARADD, another adaptor protein with a death domain (Headon et al., 2001) (Fig. 1A) .
EDAR activates canonical NF-kB
Deficiencies for EDA, EDAR or for the adaptor protein EDARADD all induce HED with similar if not identical manifestations. EDARADD, unlike FADD, does not recruit caspases, but possesses consensus binding sites for TNF receptor associated factors (TRAFs), and in particular TRAF6 (Fujikawa et al., 2013; Headon et al., 2001) . TRAF6 mediates the activation of the transcription factor NF-κB downstream of several TNF receptor family members (e.g. EDAR, RANK and CD40) or other receptors (IL1R, TLRs). Thus, Traf6-deficient mice do not only develop ectodermal dysplasia similar to Edar-or Edaradd-deficient mice, but also osteopetrosis, alymphoplasia -RANK signalling is essential for the generation of osteoclasts and lymph nodes-, B cell abnormalities -CD40 is important for B cell activation-and blunted signalling by IL1 receptor and Toll-like receptors (Naito et al., 2002) . TRAF6 is an E3 ubiquitin ligase that generates K63-linked polyubiquitin chains to which binds NEMO, the regulatory component of the inhibitor of NF-κB kinase (IKK) complex (Chen, 2012) . NEMO is on the X chromosome. Although complete NEMO-deficiency causes a severe and lethal inflammatory skin phenotype in human males, hypomorphic NEMO mutations are viable and cause HED with immunodeficiency, sometimes complicated by osteopetrosis for reasons similar to those explained above for Traf6-deficiency (Smahi et al., 2002; Zonana et al., 2000) . The crucial implication of NF-κB downstream of EDAR is demonstrated by the phenotype of IκBαΔN transgenic mice that express a non-phosphorylable, and therefore non-degradable form of a NF-κB inhibitor. These mice suffer from HED, osteopetrosis and immunodeficiency (SchmidtUllrich et al., 2001) . In embryonic skin of wild type mice, NF-κB is activated in primary hair placodes (Schmidt-Ullrich et al., 2006) . In Eda-deficient skin, there are no placodes and there is no NF-κB activation. Addition of ectopic recombinant EDA restores placodes and NF-kB signals in Eda-deficient skin, but not in IκBαΔN transgenic skin (Schmidt-Ullrich et al., 2006) . At least for the formation of primary hair placodes, NF-κB activation downstream of EDAR is not only required, but apparently also sufficient as placodes can be formed with other NF-kB stimulators such as TNF or LPS (Schmidt-Ullrich et al., 2006) (Table 1) (Fig. 2) . Table 1 is a compilation of phenotypes observed upon genetic modifications of genes related to processes also regulated by EDAR-signalling. Figure 2 is a partial, naïve and certainly incorrect view of how these gene products may interact with each other in the early phases of hair and tooth development.
The EDA -EDAR pathway is an important effector of Wnt signalling, and in turn promotes further Wnt signalling Primary hairs do not form in Edar-deficient or in Wnt signalling-deficient (deletion of β-catenin) mice (Headon and Overbeek, 1999; Huelsken et al., 2001) . Early studies in conditional β-catenin knock-out mice, where β-catenin was deleted in epithelial cells with a Keratin14 promoterdriven Cre recombinase, concluded that Wnt signalling might be downstream of EDAR, as Edar was the only placode marker still expressed in β-catenin-deficient E15.5 skin (Huelsken et al., 2001) . Also, Edar expression was unaffected in Lef-1-null skin and tooth buds (Laurikkala et al., 2001; Laurikkala et al., 2002) . This conclusion that Edar was not a Wnt-responsive gene was subsequently revised when β-catenin was deleted with another Keratin14 promoter-driven Cre recombinase with more precocious expression. Indeed, Edar expression and NF-κB activation in E14.5 skin was absolutely dependent on β-catenin activity in the epithelium, and Edar was characterized as a direct Wnt target gene (Zhang et al., 2009) . Likewise, initial uniform expression of Eda is also Wnt-dependent (Durmowicz et al., 2002; Laurikkala et al., 2001; Zhang et al., 2009) . Although Wnt signalling acts upstream of EDAR in primary hair placodes, maintenance of β-catenin activity in primary placodes at a later stage requires EDAR activity (Zhang et al., 2009) . EDAR signalling induces expression of Wnt10b, a direct NF-κB target gene, which is a good candidate to mediate the second round of β-catenin signalling in placodes (Zhang et al., 2009) . Interestingly, forced EDAR-signalling (by expression of a constitutively active LMP-EDAR fusion receptor) in primary hair placodes in the context of Wnt inhibition (by expression of the Wnt inhibitor DKK1) failed to rescue expression of EDAR target genes such as Shh, indicating that expression of Wnt-dependent genes other than Eda and Edar is required for successful EDAR signalling (Zhang et al., 2009) (Fig. 2) .
Development of skin-derived appendages
Skin-derived appendages, such as hair, teeth, and mammary glands have different function and structure but share common developmental aspects. The first step of development is the formation of a thickening of the epithelial layer, the placodes, accompanied by the condensation of the underlying mesenchyme. Placodes are embryonic signalling centres that express signalling molecule such as Wnt, FGF, TGFβ, Hedgehog and TNF family proteins (Laurikkala et al., 2002; Mikkola, 2007) . In the next step of development, placodes invaginate into the mesenchyme to form buds that further grow and develop in organ-specific manners. Interactions between the epidermal and underlying dermal cells and tissues are common and recurrent themes of skinderived organ development.
Development of hair
In mice, hair development occurs in three distinct and successive waves giving rise, respectively, to guard, awl and auchene, and zigzag hair types. The first wave of hair placodes is visible at E13.5, and the second and third are initiated at E16 and E18 (Schmidt-Ullrich and Paus, 2005) . The placode is formed by a clustering of epidermal keratinocytes in response to a signal from the dermis that could be Wnt or a Wnt inducer. Placodes express inducing molecules to re-enforce signalling, and inhibitors to prevent differentiation at the periphery of placodes until a regular array of hair follicles is established (Millar, 2002; Schmidt-Ullrich and Paus, 2005) . Each placode induces underlying mesenchymal cells to aggregate and form the dermal condensate (Millar, 2002) . This is followed by proliferation and down growth of epithelial cells into the dermis until they surround the dermal condensate that becomes the dermal papilla. Lateral communication between the dermal papilla and the follicular epithelium induces proliferation of epithelial matrix cells that give rise to different hair follicle lineages forming first the different cell types of the inner root sheath (Henley's layer, Huxley's layer and cuticle) and then those of the mature hair shaft (cuticle, medulla and cortex) (Millar et al., 1999) . The inner root sheath is surrounded by the companion cell layer and by the outer root sheath that is contiguous and similar to the epidermal basal layer.
Development of teeth
In teeth, the odontogenic signal originates form the epithelium at E11. At E12, placode cells proliferate into the underlying mesenchyme to form a bud. At E13.5 the mesenchyme condenses around the bud, expresses signalling molecules and transcription factors and instructs the epithelium to form the primary enamel knot at the tip of the bud. The primary enamel knot is a non-proliferating signalling centre important to stimulate cell proliferation in surrounding tissues. The primary enamel knot thus regulates folding of the tooth epithelium in a cap-shaped structure at E14.5 (Dassule et al., 2000; Jernvall and Thesleff, 2000) . At the bell stage (E16), the condensed mesenchyme -now called the dental papilla-is completely enclosed by the invaginating tooth epithelium. Enamel knots are transient structures that disappear by apoptosis at the end of the cap stage (Jernvall and Thesleff, 2000) . Incisor tooth germs have a single enamel knot, whereas molars additionally form secondary enamel knots at the bell stage to fold the enamel epithelium again and form multi-cuspids teeth. The final tooth shape is defined by the folding of the inner enamel epithelium and by the growth of the dental papilla (Caton and Tucker, 2009 ).
Wnt and Wnt inhibitors
Wnt/β-catenin signalling is crucial for the development of ectodermal appendages at early and later stages of differentiation (Andl et al., 2002; Huelsken et al., 2001; Liu et al., 2008; Millar, 2002; Schmidt-Ullrich and Paus, 2005; van Genderen et al., 1994) . The canonical Wnt pathway requires β-catenin. When Wnt is absent, β-catenin is eliminated by the action of the AXIN complex, which triggers β-catenin to proteasomal degradation. When Wnt is present, it binds to Frizzled receptor and to LRP5/6 co-receptors, which recruit Dishevelled (DVL), resulting in LRP5/6 phosphorylation and recruitment of the AXIN complex. This inhibits β-catenin degradation. Accumulated β-catenin translocates to the nucleus where, in complex with T cell factor/lymphoid enhancer factor (LEF/TCF), it activates expression of Wnt target gene (MacDonald et al., 2009) . Negative regulators of Wnt signalling include DKKs (Andl et al., 2002) and Sostdc1 (also known as Ectodin or Wise) (Ahn et al., 2010; Narhi et al., 2012) . Both negatively regulate LRP5/6 co-receptors and therefore Wnt signalling, either directly (Sostdc1) (Itasaki et al., 2003; Li et al., 2005; Lintern et al., 2009) or additionally via engagement of Kremens (DKKs) (Wang et al., 2008) (Fig.2) . Dkks are Wnt-and NF-κB-responsive (Andl et al., 2002; Fliniaux et al., 2008; Zhang et al., 2009 ), whereas Sostdc1 is activated by BMPR signalling (Laurikkala et al., 2003; Mou et al., 2006) . Sostdc1 is also a BMP antagonist (Laurikkala et al., 2003) , but the phenotype of Sostdc1-deficient mice that is characterized by enlarged enamel knots, additional teeth, enlarged mammary buds, enlarged hair placodes and ectopic whiskers (Ahn et al., 2010; Kassai et al., 2005; Narhi et al., 2012) , is probably due to an upregulation of the Wnt signalling pathway (Ahn et al., 2010; Narhi et al., 2012) . Endogenous expression of Dkk1 in the dermal condensate is suppressed by DKK1 overexpression, suggesting that it is a direct target of Wnt signalling involved in a negative feedback loop (Andl et al., 2002) .
TGFβ family members BMP, Activin, and their inhibitors
BMPs are known as placode inhibitors (Botchkarev et al., 1999) , but also provide positive signals for the differentiation of inner root sheath cells (Kobielak et al., 2003) , generation and decay of enamel knots (Jernvall et al., 1998) or differentiation of ameloblasts . The action of BMP is restricted by expression of a range of antagonists: Sostdc1 (Laurikkala et al., 2003) , CTGF (also known as CCN2) (Mou et al., 2006; Pummila et al., 2007) , Noggin (Botchkarev et al., 1999) and Follistatin . Cell responses to BMP are often regulated by gradients. In the hair follicle, Bmpr1a ablation prevents differentiation of matrix cells to inner root sheath cells, and therefore prevents hair shaft formation (Andl et al., 2004; Kobielak et al., 2003) . A model for the differentiation of matrix cells to inner root sheath cells takes into account the seemingly contradictory observations that BMPR1a signalling inhibits Lef-1 expression, yet is required for β-catenin/LEF-1 activation (Kobielak et al., 2003) . In the hair follicle, the dermal papilla produces Noggin that inhibits BMP signalling in the nearby proliferating epithelial matrix cells. Inhibition of BMP signalling induces Lef1 and Bmp4 expression in matrix cells, but β-catenin/LEF-1 activation does not take place in the absence of BMPR1a signalling, possibly due to down-regulated expression of Wnt receptors or to an other cause. Absence of Wnt signalling thus prevents differentiation of proliferating matrix cells. As proliferating cells move upwards and away from the source of Noggin, they start responding to their own BMP4 to become Wnt-responsive. Despite Lef-1 downregulation, stabilized LEF-1 protein is sufficient to ensure efficient β-catenin/LEF-1 activation and expression of Wntresponsive genes (e.g. hair keratins, Foxn1, Msx1, Msx2 and GATA3) involved in the differentiation of matrix cells to inner root sheath cells, which themselves will give rise to hair shaft cells (Kobielak et al., 2003) . ActivinβA is a TGFβ family member involved in tooth and whiskers formation (Ferguson et al., 1998; Jhaveri et al., 1998; Matzuk et al., 1995) . ActivinβA, its receptor ACTRII and its effector SMAD2 are all essential for the development of incisors and mandibular molars (Ferguson et al., 1998; Ferguson et al., 2001) . Follistatin inhibits ActivinβA (Jhaveri et al., 1998; Matzuk et al., 1995; Wang et al., 2004) (Fig. 2) .
Sonic hedgehog
Sonic hedgehog (SHH), a member of the Hedgehog family, is a secreted protein important for organizing dermal cells into a dermal condensate (Chiang et al., 1999; St-Jacques et al., 1998) . At a subsequent developmental stage, it induces proliferation of epithelial cells (Dassule et al., 2000; Hardcastle et al., 1998) . Binding of SHH to Patched releases the inhibition imposed on Smoothened that in turn can convert the Gli transcription factors from transcriptional repressors to transcriptional activators (Fig. 2) .
FGF
FGFs promote cell growth and proliferation. The direct Wnt target genes FGF4 and FGF8 produced in the epithelium are essential for tooth development (Kratochwil et al., 2002; Wang et al., 2009) . Interestingly, FGF8 controls expression of activinβA, that is essential for mandibular (but not maxillary) molar development, and of the homeobox genes Dlx1 and Dlx2 that are required for maxillary (but not mandibular) molar development ) (and references therein). In chickens, the scaleless mutation disrupts the Fgf20 gene and results in naked, featherless and scaleless birds (Wells et al., 2012) . In mice, Fgf20 is required for the formation of dermal condensations in primary and most secondary developing hair follicles, resulting in mice with no guard, reduced awl and auchene, and normal zigzag hair, in addition to moderately abnormal teeth (Haara et al., 2012; Huh et al., 2013) . MAPK activation by FGF receptors is inhibited by Sprouty proteins, which are commonly induced by FGF action (Fig. 2) .
Molecular targets of EDAR signalling
EDA and EDAR are important for the development of some but not all placodes (Laurikkala et al., 2002; Schmidt-Ullrich et al., 2006) . EDA plays a role for stabilizing primary hair placodes, more that initiating them, as suggested by the presence of transient hair pre-placodes at E14 in Eda-deficient skin (Mou et al., 2006; Schmidt-Ullrich et al., 2006) . Even when EDAR signalling is dispensable for placode formation, it often regulates morphology of the appendage or gland (Hammerschmidt and Schlake, 2007; Pispa et al., 1999; Schmidt-Ullrich et al., 2006; Voutilainen et al., 2012; Wells et al., 2010) . EDAR signalling potentially interacts with all major morphogenesis pathways (Fig. 2) . EDAR regulates expression of Edar itself (Mou et al., 2006) , Wnt10b (Zhang et al., 2009) , Dkk4 (Fliniaux et al., 2008) , Shh (Pummila et al., 2007) , Ctgf (Mou et al., 2006; Pummila et al., 2007) , Follistatin (Pummila et al., 2007) and Fgf20 (Haara et al., 2012; Huh et al., 2013) . BMP4 strongly inhibits Edar expression in embryonic skin and could explain its negative role on primary placode formation (Mou et al., 2006) . The induction of BMP inhibitors may locally protect the placode from BMP action, while the immediately surrounding tissue down-regulates Edar (Mou et al., 2006) . Production of Wnt inhibitors may also contribute to downregulate Edar and other relevant genes at the periphery of placodes. The absence of Shh and Fgf20 expression in primary hair pre-placodes of Eda-deficient skin, and reduced production in Eda-deficient enamel knots certainly explains much of the absence of guard hair and of the molar defects of Eda-deficient mice (Haara et al., 2012; Huh et al., 2013; Pispa et al., 1999; Pummila et al., 2007) . In addition, the branching defect observed in salivary glands of Edadeficient mice can be rescued in cultured organ explants with ectopic SHH (Wells et al., 2010) , supporting a relevant role for SHH downstream of EDAR.
Mouse and dog models of X-linked hypohidrotic ectodermal dysplasia
In the mouse, loss-of-function mutations of Eda cause the Tabby phenotype, which is the mouse counterpart of XLHED Srivastava et al., 1997) . Tabby mice have a single abnormal awl-like hair type, no hair on the tail, lack the fine hair behind the ears but have hair on the ear skin. They lack sweat glands, mebomian glands, tracheal glands and present more or less marked abnormalities in sebaceous glands, mammary glands and salivary glands (Gruneberg, 1971) . A dog model of XLHED is also available (Casal et al., 1997) , in which a mutation in a splice site of EDA prevents protein expression (Casal et al., 2005) . Affected dogs lack sweat glands, have bald patches around the body and lack secondary hair. They present abnormal or missing teeth, suffer from dry eyes and from recurrent airways infections due to abnormal mucus secretion in bronchi and trachea (Casal et al., 1997; Casal et al., 2005) . Thus, HED dogs recapitulate several of the clinically relevant defects of XLHED patients.
Pharmacological activators of EDAR
Fc-EDA1 is an EDAR agonist. It is a fusion protein between the effector portion (Fc fragment) of human IgG1 and the C-terminal, THD domain of EDA1 (Gaide and Schneider, 2003) . As the Fc is a dimer and the THD is a trimer, the fusion protein mainly assembles as hexamers containing three Fc and two THD (Fig. 1C) . The protein lacks the difficult-to-express collagen domain of EDA, whose aggregating function is mimicked by fusion with the Fc. Fc-EDA1 also lacks the proteoglycan-binding portion that prevents access of recombinant EDA to relevant tissues in vivo upon intra-peritoneal administration (Swee et al., 2009 ). The Fc portion of Fc-EDA1 is also important to a) enhance half-life of the protein in vivo, an effect that is well-known to be mediated by binding to neonatal Fc receptors (FcRn), and b) allow transport from the maternal circulation to the circulation of the foetus via the trans-placental antibody transport system, which allows exposure of foetuses to the protein in utero. Fc-EDA1 can substitute for endogenous EDA1 to correct many phenotypic abnormalities of Eda-deficient mice or dogs, including permanent teeth in mice and the secondary dentition in dogs (Casal et al., 2007; Gaide and Schneider, 2003; Mauldin et al., 2009 ). In dogs, post-natal administration of Fc-EDA1 had several direct clinical benefits: it permanently abolished the dry eye phenotype (reverted dogs no longer needed the chronic eye drop treatment required by affected dogs) and improved mucociliary clearance in the airways, a feature that correlated with a drastic reduction of airways infections and courses of antibiotic treatments (Casal et al., 2007) . Several anti-EDAR antibodies raised in Edar-deficient mice display in vivo activities similar to that of Fc-EDA1 when administered to Eda-deficient mice or dogs (Kowalczyk et al., 2011) . Several hallmarks of the reversion of Eda-deficient animals with EDAR agonists are worth mentioning. A first feature is the life-long phenotypic correction achieved by a short-course treatment, indicating that EDAR provides an inductive rather than a maintenance signal (Gaide and Schneider, 2003; Kowalczyk et al., 2011) (Fig. 3) . However, hair and their associated sebaceous glands are known exceptions in which the EDA-EDAR pathway remains active and can be regulated in adult life (Cui et al., 2003; Fessing et al., 2006 ) (CKQ and PS, unpublished data). The effect of chronic EDARagonist treatment on hair and their associated sebaceous glands will be interesting to study in the future. A second important feature of treatment efficacy is its relatively narrow therapeutic window, which depends on the ability of developing tissues to respond to EDA (Gaide and Schneider, 2003) . Finally, the surprising fidelity with which tooth morphology can be corrected in Eda-deficient animals treated with a vast excess of "artificial" soluble EDAR agonists is certainly due to the fact that EDAR expression and its ability to signal and initiate regulatory feed-forward and feed-back responses are all intact in Eda-deficient animals. Another example is the restoration, in mice, of tail hairs regularly arranged by groups of three, which is remarkable considering that the skin of the tail is completely naked in the absence of treatment (Gaide and Schneider, 2003; Kowalczyk et al., 2011) . However, soluble agonists do not restore the characteristic morphology of zigzag hairs with three evenly spaced and well-marked kinks. These kinks find their origin in the asymmetric expression of Eda in matrix cells of the hair follicle, which periodically shifts from one side of the hair follicle to the other, while Edar is continuously expressed on both sides of the follicle (Hammerschmidt and Schlake, 2007) . EDAR signalling in the follicle, as judged by Shh and Saa3 expression -Saa3 is a NF-κB responsive gene-reflects the Eda expression pattern, suggesting that EDA acts locally (Hammerschmidt and Schlake, 2007) , possibly because the proteoglycan-binding domain restricts the diffusion of soluble EDA (Swee et al., 2009) . If this model is true, the prediction is that soluble agonists will never rescue zigzag hairs or any process that requires polarized expression of Eda. Of note, a clinical trial to test the efficacy of a human form of Fc-EDA1 has recently been initiated in newborn patients with XLHED.
Pharmacological inhibitors of EDAR
Recombinant or endogenous EDA1 can be inhibited in vitro or in vivo with a soluble decoy EDAR-Fc fusion protein containing the extracellular, receptor-binding domain of EDAR (Fessing et al., 2006; Swee et al., 2009) (Fig. 1C) . Function-blocking anti-EDA monoclonal antibodies have been raised in Eda-deficient mice. They block EDA at close to stoichiometric ratio and can induce ectodermal dysplasia in mice (Kowalczyk-Quintas et al., 2014) . The availability of monoclonal mouse antibodies able to block and/or activate EDAR signalling in vivo will be useful to study this pathway during or after development.
Conclusion
Ectodysplasin A1 and its receptor EDAR are important for the development and function of several, but not all, ectodermal appendages. This system is part of a complex process of cell communication and differentiation involved in morphogenesis, which has been best characterized during development of mouse teeth and primary hairs, but whose common themes also apply at least in part to other structures and species. EDAR signalling occurs rather late in development and affects a defined set of organs. Available genetic data identified much of the mechanism and implications of EDAR signalling. The availability of pharmacological modulators of the pathway raises hope to use this knowledge for the treatment of certain forms of ectodermal dysplasia. Modulation of the EDAR signalling pathway may also find applications in pathologies involving Edar-regulated glands and organs. (Jarvinen et al., 2006; Liu et al., 2008; Narhi et al., 2008; Zhang et al., 2008) β-catenin K14-Cre;β-catenin (medium Cre)
Viable. Block of hair development in β-catenin-deleted skin areas. Body hair that form are lost at 2 week of age. (Huelsken et al., 2001; Zhang et al., 2009) β-catenin K14-Cre;β-catenin (early Cre)
Viability not mentioned. Block of hair development. Loss of patterned β-catenin activity in E13.5 to E14.5 dermis. (Huelsken et al., 2001; Zhang et al., 2009) ActivinβA
ActivinβA-null
Lethal at P1. No whiskers. Incisor and mandibular molar failed to develop beyond the bud stage. Maxillary molars unaffected. (Ferguson et al., 1998; Jhaveri et al., 1998; Matzuk et al., 1995) ActivinRIIA+B
ActRIIB-null +ActRIIA-het
Lethal at birth. Similar to ActivinβA-null. Partial penetrance of tooth phenotype. BMPR1a K14-Cre;Bmpr1a Viable. Gene expression from E14 to E14.5. Focal alopecia behind the ears. No sweat glands. Thin hair without bends, no zigzag hair. Guard hairs present but shorter. (Hammerschmidt and Schlake, 2007) EDA Eda-deficiency Tabby mice. Viable. Alopecia behind the ears, no tail hair, no sweat glands, no mebomian glands, no tracheal glands, lack of several other glands, abnormal hair coat (only zigzag hair with abnormal awl-like morphology), smaller molars with fewer cusps, third molar sometimes lacking. Small eye opening, thickened eyelids. (Gruneberg, 1971; Hammerschmidt and Schlake, 2007; Pispa et al., 1999) (Cui et al., 2003; Mustonen et al., 2003) EDAR Edar-deficiency Downless and Sleek mice. Viable. Same phenotype as Edadeficient mice. (Headon and Overbeek, 1999) EDAR
EDA1

Tg951 (~20 copies of YAC transgene)
Sebaceous and mebomian glands are enlarged, salivary and mammary glands are more elaborately and more branched, enlarged hair follicles, thicker hair fiber. (Chang et al., 2009; Mou et al., 2008) EDARADD
Edaradd-null
Crinkled mice. Deletion. Viable. Same phenotype as Edadeficient mice. (Falconer et al., 1951; Headon et al., 2001) 
FGF20
Fgf20-null (knock-in with βGal)
Smaller molars, reduced crown area. No guard hair, reduced numbers of awl and auchene hair, normal zigzag hair. Placodes are generated for missing hair, but no dermal condensation form underneath. (Haara et al., 2012; Huh et al., 2013) 
FGF20
Fgf20-deficiency
Scaleless mutant in chicken. Non-sense mutation in Fgf20. No feathers and scales. (Wells et al., 2012) Follistatin K14::follistatin Viable. Inhibition of ameloblasts differentiation in incisors. No enamel. Follistatin
Follistatin-null
Lethal soon after birth. Retarded growth. Diaphragm, muscle and skeletal defects. Shiny taut skin. Thin and curly whiskers. Molar cusps defects, ameloblasts differentiate ectopically on the lingual enamel-free surface of the incisor. (Jhaveri et al., 1998; Matzuk et al., 1995; Wang et al., 2004) GLI2, GLI3 Gli2-null, Gli3-null Lethal around E10.5, few embryos survive to E14.5. Incisors blocked at bud stage, no sign of molar development. (Hardcastle et al., 1998) IκBα ki of IκBαΔN (super-repressor) in β-catenin locus Viable. Alopecia behind the ears, no tail hair, no sweat glands, no mebomian glands, abnormal hair coat (single awl-like hair type). Reduced number of hair follicles. Delayed outgrowth of incisors and molars. Abnormal incisor positioning. No lymph nodes, osteopetrosis, immuno-deficiency. (Ohazama et al., 2004; SchmidtUllrich et al., 2001; Schmidt-Ullrich et al., 2006) LEF-1 K14::Lef1
Viable. Aberrant patterning of the hair on the body. Inappropriate eruption of hair and tooth-like structures in the oral epithelium (Zhou et al., 1995) LEF-1 Lef1-null Lethal at birth. Lack of vibrissae and body hair. Tail hair and sweat gland present. Tooth development arrest at bud stage. Lack of mammary gland (van Genderen et al., 1994) 
NEMO/IKKγ mutations in human
On the X chromosome. Complete deficiency is lethal. Heterozygous females develop incontinentia pigmenti. Males with hypomorphic mutations have hypohidrotic ectodermal dysplasia with immunodeficiency (HED-ID). Males with stop (Smahi et al., 2002; Zonana et al., 2000) codon mutations have in addition osteopetrosis and lymphedema (OL-HED-ID (Plikus et al., 2004) Noggin K5::Noggin Increased size of anagen hair follicles, replacement of zigzag and auchene hairs by awl-like hairs (no more hair with bends). Noggin
Noggin-null
Reduced hair placode number. Hair development arrest at bud stage. (Botchkarev et al., 1999) SHH Foxn1::Shh Viable. Expression mainly in hair cortex. Attenuation of kinks in zigzag hair attributed to altered polarity of follicles. (Hammerschmidt and Schlake, 2007) SHH Shh-null, and grafted embryonic null skin Lethal at birth. The first branchial arch giving rise to jaw mandibles does not form. Hair development blocked at placodes and dermal condensate stage. Reduced number of hair follicles. (Chiang et al., 1999; St-Jacques et al., 1998) 
SHH
K14-Cre;Shh
Lethal at birth. Deletion at E12.5, (still expressed at E11.5). Opened eyes. No whiskers. Jaws present. Small and abnormally shaped incisors and molars. Defect at cap stage (E14.5), functional enamel knot, severe defect of epithelial cells downgrowth on the lingual side where Shh is normally expressed). Ameloblasts and odontoblasts still differentiate. (Dassule et al., 2000) SMAD2
Smad2-het
Lethal at birth. Similar to ActivinβA-null. Partial penetrance of tooth phenotype. 
Sostdc1
Sostdc1-null
Viable. Enlarge enamel knot, supplementary incisors and molars, fused molars and cusps defect. Enlarge hair and mammary placodes. Ectopic whiskers. (Ahn et al., 2010; Kassai et al., 2005; Narhi et al., 2012) Sostdc1/Ectodin K14::Sostdc1
Viable. Reduced tooth size, loss of the M3 molar, and cusps defect. Abnormal development of hair follicle. (Ahn et al., 2010; Ahn et al., 2013) 
TRAF6
Traf6-null
Viable. No guard hair, sweat glands, sebaceous glands, mebomian glands, anal glands, and preputial glands. Alopecia behind ears, hairless tail with kink. Severe osteopetrosis, alymphoplasia, abnormal B cells, impaired IL1R and TLR signaling. (Naito et al., 2002) work was supported by grants from the Swiss National Science Foundation to PS. CKQ is supported by a research grant of Edimer Pharmaceuticals. Long-term reversion of hair (tail, guard, retro-auricular), eye and functional sweat glands in a 21 months-old Eda-deficient mouse treated at days 8.5 and 13.5 of gestation with 4 mg/kg of an agonist anti-EDAR monoclonal antibody (mAbEDAR3 (Kowalczyk et al., 2011) ). 
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